Combined, elobixibat, and colestyramine reduced cholesterol toxicity in a mouse model of metabolic dysfunction-associated steatotic liver disease

Iwaki, M; Kessoku, T; Tanaka, K; Ozaki, A; Kasai, Y; Kobayashi, T; Nogami, A; Honda, Y; Ogawa, Y; Imajo, K; Usuda, H; Wada, K; Kobayashi, N; Saito, S; Nakajima, A; Yoneda, M

Yoneda, M (通讯作者)，Yokohama City Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, 3-9 Fukuura,Kanazawa Ku, Yokohama 2360004, Japan.

HEPATOLOGY COMMUNICATIONS, 2023; 7 (11):

Abstract

Background: Cholesterol levels and bile acid metabolism are important drivers of metabolic dysfunction-associated steatohepatitis (MASH) progression. ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索